Cargando…
Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas
OBJECTIVE: To elucidate the mechanism of the unique beneficial effect of intravitreal steroid therapy on diabetic macular edema, we investigated the effect of locally administered triamcinolone acetonide (TA) on the expression of vascular endothelial growth factor (VEGF)-A and its receptors in retin...
Autores principales: | Zhang, Xinyuan, Bao, Shisan, Lai, Donna, Rapkins, Robert W., Gillies, Mark C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836241/ https://www.ncbi.nlm.nih.gov/pubmed/18174522 http://dx.doi.org/10.2337/db07-0982 |
Ejemplares similares
-
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016) -
Patients treated with intravitreal triamcinolone acetonide
por: Gallenga, Pier E, et al.
Publicado: (2008) -
Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits
por: Ye, You-Fan, et al.
Publicado: (2014) -
Retinal Capillary Hemangioma Treated with Verteporfin Photodynamic Therapy and Intravitreal Triamcinolone Acetonide
por: Suh, Shin Cho, et al.
Publicado: (2007) -
Retinal Microvascular Changes after Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
por: Kato, Fusae, et al.
Publicado: (2023)